Palumbo Wealth Management’s Sana Biotechnology SANA Stock Holding History

Palumbo Wealth Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	59,773 +1,314	+2%	+$4.23K	0.04%	227
2026 Q1	$168K	Sell	58,459 -62,524	-52%	-$246K	0.04%	214
2025 Q4	$492K	Buy	120,983 +9,695	+9%	+$43.4K	0.12%	124
2025 Q3	$395K	Buy	111,288 +30,195	+37%	+$109K	0.13%	111
2025 Q2	$221K	Buy	+81,093	New	+$167K	0.07%	176

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Palumbo Wealth Management's SANA Position: Q2 2026 in Review

Palumbo Wealth Management increased its Sana Biotechnology (SANA) stake by 2.2% in Q2 2026, buying an estimated $4.23K and bringing the position to 59,773 shares worth $209K. The position accounts for 0.04% of the portfolio, ranked #227.

Palumbo Wealth Management first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. The position peaked at $492K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Palumbo Wealth Management held 59,773 shares of Sana Biotechnology worth $209K as of Q2 2026.
Palumbo Wealth Management bought 1,314 Sana Biotechnology shares in Q2 2026, an estimated $4.23K.
Sana Biotechnology made up 0.04% of Palumbo Wealth Management's portfolio in Q2 2026, its #227 holding.
Palumbo Wealth Management first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
Palumbo Wealth Management's Sana Biotechnology position peaked at $492K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.